Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Open Water Rx vs Synergy Rx

Two GLP-1 desks, one scoreboard. We put Open Water Rx and Synergy Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 400 · Grade C

Open Water Rx

Visit Open Water Rx Full brief →
vs
Higher Brief ScoreNo. 145 · Grade C

Synergy Rx

Visit Synergy Rx Full brief →

The verdict

Synergy Rx takes this head-to-head.

Synergy Rx scores 67 to 56 on our six-factor Brief Score — One of the few desks in this ranking that names both its prescribers and its pharmacies — wrapped around an intro rate that steps up in month two, an $80 visit fee that appears in no headline, and an ODT bundle ladder that costs more per month than not bundling.

That doesn't make Open Water Rx a bad call — it's best for readers who want transparency listing only — verify against vetted providers first. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
58
54
Supply Reliability
46
82
Transparency
72
60
Access Breadth
62
62
Clinical Oversight
54
84
Track Record
40
66
Open Water RxBrief Score 56 · 67Synergy Rx

Price, coverage & the tracker

Open Water RxSynergy Rx
Brief Score56/100 (C)67/100 (C)
SemaglutideFrom $249/mo (compounded)$249/mo ongoing, compounded ($199 first month only) + an $80 visit fee charged whether or not you get medication
TirzepatideFrom $339/mo (compounded)$399/mo ongoing, compounded ($349 first month only); the ODT bundles price HIGHER, at $399.67–$399.92/mo
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
On the trackerNewnew to the tracker, no prior readingNewnew to the tracker, no prior reading

Open Water Rx: New to the tracker on 1 August 2026. The published line reads From $249/mo (compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Synergy Rx: First reading, 7 August 2026. Ongoing month-to-month is $249 semaglutide and $399 tirzepatide; the $199 and $349 figures carried in older datasets are first-month-only rates. An $80 telehealth visit fee sits outside every headline and is charged whether or not medication is dispensed.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.